Viewing Study NCT02446860


Ignite Creation Date: 2025-12-25 @ 2:16 AM
Ignite Modification Date: 2026-01-06 @ 11:32 PM
Study NCT ID: NCT02446860
Status: TERMINATED
Last Update Posted: 2025-06-06
First Post: 2015-03-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Anti-PD1 (Nivolumab) Therapy as Pre- and Post-operative Therapy in Metastatic Renal Cell Cancer (ADAPTeR)
Sponsor: Royal Marsden NHS Foundation Trust
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-04
Start Date Type: None
Primary Completion Date: 2018-08
Primary Completion Date Type: ACTUAL
Completion Date: 2018-08
Completion Date Type: ACTUAL
First Submit Date: 2015-03-12
First Submit QC Date: None
Study First Post Date: 2015-05-18
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2025-06-03
Last Update Post Date: 2025-06-06
Last Update Post Date Type: ACTUAL